Metabolic & IncretinCAS: 2381089-83-2Mass: 4731.33 Da
Retatrutide (LY3437943)
Investigational triple-receptor agonist targeting GIP, GLP-1, and glucagon receptors simultaneously, widely studied in preclinical and clinical metabolic models for energy expenditure and lipid oxidation.
Chemical Class / Sequence39-amino-acid acylated triple GIP/GLP-1/GCGR agonist
Known Storefront Code AliasesRT-3 · GLP-3 · Triple G · RP-3 · SR-3RT · GL-3 RT · NS-3RT · RTA GLP-1
🔬 COA Analytical Verification Note: Because many storefronts list Retatrutide under shorthand codes (RT-3, GLP-3, Triple G), researchers must verify LC-MS molecular mass (~4731.3 Da) or blind GLP-1 screening on the batch COA.
Standard Volumetric Reference: 2.0 ml BAC water into 10 mg vial → 5,000 mcg/ml (50 mcg per 1 IU tick)
Open U-100 Calculator →🇪🇺 Top Verified EU Domestic Lab
CertaPeptides
★ 4.1/5.099.4% mean HPLC across 49+ public Janoshik keys · 2–5 business days intra-EU dispatch (no EU customs)
🇺🇸 Top Verified US Domestic Lab
Arctic Lab Supply
★ 3.6/5.098.07%–99.91% across 20 lot-matched reports · Same-day USPS Priority from Anchorage (3–6 days US; ships intl)
True $/mg & €/mg Audited Batches for Retatrutide (LY3437943)
| Supplier | Label → COA mg | Lab & Purity | True Price/mg |
|---|---|---|---|
| CertaPeptides | 10 mg → 10.62 mg (+6.2%) | 99.48% · Janoshik Analytical | €11.21/mg |
| Avellon Peptides | 10 mg → 10.34 mg (+3.4%) | 98.92% · Janoshik Analytical | €10.54/mg |
| PeptidProfi | 10 mg → 9.68 mg (-3.2%) | 99.21% · Janoshik Analytical | €11.88/mg |
| Arctic Lab Supply | 10 mg → 10.48 mg (+4.8%) | 99.41% · ILS Laboratories | $10.97/mg |
| Source Research | 10 mg → 10.39 mg (+3.9%) | 99.68% · ILS + Vanguard Dual-Panel | $11.93/mg |
| GhostLabz Research | 10 mg → 10.55 mg (+5.5%) | 99.32% · ILS Laboratories | $10.43/mg |
| NextSelf Labs | 10 mg → 12.14 mg (+21.4%) | 99.62% · ILS Laboratories | $9.72/mg |